Oaktree Acquisition Corp. III Life Sciences (OACC) Total Current Liabilities (2024 - 2026)

Oaktree Acquisition Corp. III Life Sciences has reported Total Current Liabilities for 3 years, with the latest figure at $1.6 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities rose 53.44% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (up 53.44% YoY), and the FY2025 full-year result was $1.3 million, up 78.69% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $1.6 million, up from $1.3 million in the prior quarter.
• The five-year high for Total Current Liabilities was $1.6 million in Q1 2026, with the low at $727323.0 in Q4 2024.
• Historically, Total Current Liabilities has averaged $1.2 million across 3 years, with a median of $1.2 million in 2025.
• Annual changes were most pronounced in 2025 — Total Current Liabilities soared 78.69% — and 2026, when it surged 53.44%.
• Oaktree Acquisition Corp. III Life Sciences' Total Current Liabilities stood at $727323.0 in 2024, then surged by 78.69% to $1.3 million in 2025, then advanced by 24.97% to $1.6 million in 2026.
• The last three Total Current Liabilities figures came in at $1.6 million (Q1 2026), $1.3 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.